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Editorial
Duration of untreated psychosis: What are we
talking about?
Duration of untreated psychosis (DUP) broadly refers
to the time elapsing between onset of psychosis and
treatment initiation. Its relationship with outcome
has been intensely studied in the framework of
the development of early intervention strategies for
psychosis. Results of such research are however still
a matter of controversy, some studies showing a
negative impact of long DUP on outcome (1–4)
while others do not (5–8). In a systematic literature
review, Marshall (9) nevertheless concluded that
there is a significant, albeit small to moderate,
negative association between DUP and outcome, and
most early intervention programmes rank reduction
of DUP as a primary priority.
From a clinical point of view, reduction of DUP
emerges as a logical target when witnessing the col-
lateral damage suffered by patients who experience
long delays prior to onset of care (10). Addition-
ally, recent imaging data have shown that the pro-
drome and the early phase of psychotic disorders are
periods of active and progressive structural changes
in key brain areas such as the hippocampus (11).
If one assumes that there is an active process of
neuroprogression underlying these changes, then the
longer the DUP, the greater the time available for this
potentially neurotoxic process to unfold (12). The
nature of the pathogenic process remains to be fully
elucidated; however, it probably includes reduction
in neurotrophins, oxidative stress and inflamma-
tory cytokines. Given the evidence that appropri-
ate treatment is potentially neuroprotective (13),
reduction in DUP could therefore be associated with
reduction in potentially cumulative brain insult, and
hence improvement in symptomatic and functional
outcomes.
In the last few years, assessment of psychosis onset
has been the object of a considerable attention, and
this interest has led to both a degree of consensus
about its definition and the development of scales
specifically designed to determine the date of its
initial occurrence (14,15). A closer look at this lit-
erature reveals on the other hand that criteria applied
to define the endpoint of DUP, in other words the
time of treatment initiation, is much less consistent
and vary greatly between studies.
According to international guidelines, an adequate
treatment of first episode psychosis should combine
adapted medication (generally utilising low-dose
strategy) and psychosocial intervention delivered in
the context of easily accessible and specialised treat-
ment teams (16–18). However, despite the avail-
ability of such guidelines, the concept of ‘treatment
initiation’ usually refers to the commencement of
very incomplete and often ill-defined interventions
(Table 1). These include ‘initiation of medication’,
‘commencement of any form of treatment’, ‘initia-
tion of adequate treatment’, ‘time of first effective
treatment’, as well as ‘hospitalisation’ or ‘entry to
a specialised programme’. In addition, adherence to
treatment is in the vast majority of cases not assessed
when in fact clinical experience reveals that enroll-
ment in a specialised service or prescription of med-
ication does not necessarily equate with the person
being fully engaged with the service, receiving suf-
ficient psychosocial support, or taking medication as
prescribed.
In the studies mentioned above, it is therefore
highly likely that many patients for whom DUP
was defined as having concluded actually remained
untreated or partially treated. Only two studies
defined treatment initiation on the basis of adher-
ence to or observed response to medication treatment
(14,30). However, by focusing on this aspect of
treatment, they neglect the importance of psychoso-
cial intervention in the recovery process (31), while
recent randomised controlled trials have now clearly
proven that integrated early intervention programmes
that include specialised psychosocial treatment lead
first episode psychosis patients to a better outcome
than generic mental health programmes (32,33).
This lack of consistency in definition is concern-
ing, considering that an absence of consensus on
what ‘treatment initiation’ actually comprises could
very well be one of the critical factors that so far
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Table 1. Definitions of treatment initiation in the literature
Study Definition applied to initiation of treatment Limitations
Barnes et al. (19); Browne et al. (20); Craig et al. (5); Haas Initiation of medication • Absence of assessment of adherence to treatment
et al. (21); Ho and Andreasen, (7); Szymanski et al. (22); • Does not take into account psychological and case
Tirupati et al. (23). management intervention
Wiersma et al. (24) Any form of treatment • Absence of definition of treatment
Larsen et al. (25) Initiation of adequate treatment • Absence of definition of response
Addington et al. (26) First effective treatment • No definition of effective treatment
• Problem with treatment resistance
Hafner et al. (27); Kalla et al. (28) Hospitalisation • Selection bias towards patients with more acute
symptoms
Carbone et al. (29); Schimmelmann et al. (4) Entry to specialised programme • Does not mean patients are adherent to treatment
Malla et al. (30) Medication for at least 2 months or significant
response
• Treatment definition restricted to medication
Singh et al. (14) Medication with adherence (at least 75% of the
dose for 75% of the time)
• Treatment definition restricted to medication
limited the conclusiveness of studies exploring poten-
tial consequences of DUP. While research exploring
DUP impact on outcome should not interfere with
common sense arguments justifying the necessity
of mental health services reforms aimed at facili-
tating treatment access for patients with psychosis
(10), conclusive research on DUP, based on valid
data, would only provide more momentum to such a
reform process.
It seems therefore timely to establish a clearer
definition of what should be considered as the end
of the DUP period. First, given that medication is a
key element in treatment of the vast majority of first
episode psychosis patients, antipsychotic treatment
initiation should belong to the definition. However,
adherence to treatment ought to be assessed as well
and the medication criterion considered fulfilled only
if patients have taken their treatment for at least
75% of the time during at least 4 weeks. Second,
based on the above data supporting the efficacy
of specialised treatment, end of DUP should be
considered only when patients are well engaged
in an early intervention programme. It is clear
that psychosocial treatments remain inconsistently
available, and subject to the vagaries of service,
economic, training and resource variables, but this
is precisely what research on the impact of DUP is
all about: to show that adequate treatment provided
early has a positive impact on outcome of psychosis.
Once this point established, the argument to justify
the need for a reform of mental health programmes
and for an earlier access to adequate psychosocial and
medication treatment in early psychosis would only
be stronger. However, in order to supply evidence-
based arguments to this debate, the definition of DUP
needs to be applied with more precision.
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